» Home
» Centers
» Organization
» Meetings
» Committees
» Staff
» Documents
» Data System
» Studies
» Presentations
» Publications
» Links
» Ancillary Studies
» For Patients
Farnesoid-X nuclear receptor ligand obeticholic acid for non-cirrhotic nonalcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
NIDDK Press release
FLINT Trial protocol (May 2013)
Last updated: 10 November 2014